title: Monitoring nevirapine-based programmes for prevention of mother-to-child transmission of HIV-1.
authors.forename: Jeffrey S A
authors.initials: JS
authors.lastname: Stringer
authors.forename: Moses
authors.initials: M
authors.lastname: Sinkala
authors.forename: Robert
authors.initials: R
authors.lastname: Goldenberg
authors.forename: Sten
authors.initials: S
authors.lastname: Vermund
authors.forename: Edward
authors.initials: E
authors.lastname: Acosta
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D000914:Antibodies, Viral / Q000032:analysis; D002648:Child; D019049:Developed Countries / Q000706:statistics & numerical data; D005260:Female; D005312:Fetal Blood / Q000737:chemistry / Q000276:immunology; D015658:HIV Infections / Q000188:drug therapy / Q000517:prevention & control* / Q000635:transmission*; D015497:HIV-1 / Q000276:immunology; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D019829:Nevirapine / Q000627:therapeutic use*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D015397:Program Evaluation / Q000379:methods; D015024:Zambia
chemical_list: D019380:Anti-HIV Agents; D000914:Antibodies, Viral; D019829:Nevirapine